The rising prevalence of cancer worldwide, increasing adoption of minimally invasive diagnostic tests, and advances in ...

This infographic will explore how NGS has contributed to advances in personalized cancer treatment, microbiome research and ...

SOPHiA Genetics & Jessa Ziekenhuis partner to bring cutting edge genomic testing and oncology research to cancer patients across Belgium: Boston Monday, September 8, 2025, 16:00 H ...

The integrated platform decreases manual effort by 30–50%, reduces total expenses by up to 25%, and speeds up turnaround ...

IIT Madras and Hyundai launch India’s first Cancer Tissue Biobank to boost childhood cancer research, early diagnosis, and care access, aiming to improve survival and treatment outcomes.

The global oncology molecular diagnostics market is valued at USD 3.48 billion in 2025 and is projected to grow to USD 9.76 ...

Overview of Esoteric Testing MarketThe Global Esoteric Testing Market is valued at USD 30.56 Billion in 2024 and is projected ...

PredicineCARE, a urine-based test, is under FDA review as a companion diagnostic for bladder cancer, building on previous ...

The rapid food safety testing market continues to expand due to increasing global concerns over foodborne illnesses, stricter regulatory frameworks, and growing consumer demand fo ...

Traditional tissue biopsy is invasive, time-consuming, and often impractical in advanced or metastatic disease. Liquid biopsy—non-invasive sampling of circulating tumor DNA (ctDNA), circulating tumor ...

Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA ...